Making ?sense? of diabetes: using a continuous glucose sensor in clinical practice
- 1 January 2002
- journal article
- conference paper
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 18 (S1) , S43-S48
- https://doi.org/10.1002/dmrr.209
Abstract
Home blood glucose monitoring provides only a snapshot picture of prevailing glucose values. Continuous glucose monitoring allows identification of patterns of glucose levels for up to 72 h with details of excursions above and below target levels and thus may be a valuable adjunct tool in diabetes management. We have used the MiniMed Continuous Glucose Monitoring System (CGMS) in ten individuals and have uncovered a significant rate of hypoglycaemia that was previously undetected by conventional means. Preliminary evidence suggests that the novel technology may allow clinicians to ‘personalise’ intensive insulin therapy with improvement in glycaemic control. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 7 references indexed in Scilit:
- Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot studyDiabetes Research and Clinical Practice, 1999
- The MiniMed Continuous Glucose Monitoring System (CGMS)1999
- Episodic hyperglycaemia in pregnant women with well‐controlled Type 1 diabetes mellitus: a major potential factor underlying macrosomiaDiabetic Medicine, 1999
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Fear of Hypoglycemia: Quantification, Validation, and UtilizationDiabetes Care, 1987
- Insulin PharmacokineticsDiabetes Care, 1984